Skip to main content

Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants.

Klein RH, van der Vorst MM, de Wilde RB, Hogenbirk K, de Kam ML, Burggraaf J

Publication: Blood Coagul Fibrinolysis (2013) • Vol 24 • Page 327-31PMID: 23337708View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient age and measurement device on activated partial thromboplastin time (APTT) in specimens from patients currently or previously on heparin therapy.

Conclusion

APTT values determined in the lab using the Electra 1800C automated coagulation analyzer were not significantly different between adults and infants. The correlations between APTT values measured by the laboratory analyzer and the bedside analyzer for all specimens, those from infants only, and those from adults only were r=0.59, r=0.48, and r=0.85, respectively. The Coaguchek bedside analyzer showed a substantial positive bias for APTT measurements in specimens from infants (27 s) and adults (25 s), which tended to increase at higher APTT values.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient age and measurement device on APTT in specimens from patients currently or previously on heparin therapy. Blood specimens intended for laboratory analysis were drawn into citrate tubes while a single drop of blood was simultaneously collected through the same catheter for bedside analysis.

Summary of Findings

APTT values determined in the lab using the Electra 1800C automated coagulation analyzer were not significantly different between adults and infants. The correlations between APTT values measured using the laboratory analyzer and the bedside analyzer for all specimens, those from infants only, and those from adults only were r=0.59, r=0.48, and r=0.85, respectively. The Coaguchek bedside analyzer showed a substantial positive bias for APTT measurements in specimens from infants (27 s) and adults (25 s), which tended to increase at higher APTT values.
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
    Other diagnoses
  • Platforms

    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Underwent cardiothoracic surgery
    PreaquisitionPatient age
    <1 year old
    Adult
    Hematology/ auto analyzer SpecificTechnology platform
    Coaguchek Pro/DM coagulation device (bedside)
    Electra 1800C automated coagulation analyzer (laboratory)